McFarlane Neil F. Insider Trades & Stock Holdings

President and CEO · Zevra Therapeutics, Inc. · Latest filing Oct 12, 2026

McFarlane Neil F., President and CEO at Zevra Therapeutics, Inc. has 1 Form 4 trade on file since Oct 12, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($224.95K), net -$224.95K. Latest filing: disposed of 20K shares of $ZVRA on Oct 12, 2026 at $11.25.

Trades on file
1
Open-market bought
$0
Open-market sold
$224.95K
Net open-market
-$224.95K
Latest filing
Oct 12, 2026

All insider trades by McFarlane Neil F.

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$ZVRA Sell (Open-market sale) 10b5-1 20K $11.25 $224.95K President and CEO Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks McFarlane Neil F. traded

Frequently asked questions

Has McFarlane Neil F. been buying or selling stock?

McFarlane Neil F. has 0 open-market purchases and 1 open-market sale on file, net -$224.95K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was McFarlane Neil F.'s latest insider trade?

disposed of 20K shares of $ZVRA on Oct 12, 2026 at $11.25.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions